Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 171

1.

Autoantibodies against heterogeneous nuclear ribonucleoprotein B1 in CSF of MS patients.

Sueoka E, Yukitake M, Iwanaga K, Sueoka N, Aihara T, Kuroda Y.

Ann Neurol. 2004 Dec;56(6):778-86.

PMID:
15497154
2.

Significantly increased antibody response to heterogeneous nuclear ribonucleoproteins in cerebrospinal fluid of multiple sclerosis patients but not in patients with human T-lymphotropic virus type I-associated myelopathy/tropical spastic paraparesis.

Yukitake M, Sueoka E, Sueoka-Aragane N, Sato A, Ohashi H, Yakushiji Y, Saito M, Osame M, Izumo S, Kuroda Y.

J Neurovirol. 2008 Apr;14(2):130-5. doi: 10.1080/13550280701883840.

PMID:
18444084
3.

Identification of autoantibodies to the I protein of the heterogeneous nuclear ribonucleoprotein complex in patients with systemic sclerosis.

Montecucco C, Caporali R, Cobianchi F, Biamonti G.

Arthritis Rheum. 1996 Oct;39(10):1669-76.

PMID:
8843857
4.

Multiple specificities of autoantibodies against hnRNP A/B proteins in systemic rheumatic diseases and hnRNP L as an associated novel autoantigen.

Siapka S, Patrinou-Georgoula M, Vlachoyiannopoulos PG, Guialis A.

Autoimmunity. 2007 May;40(3):223-33.

PMID:
17453722
5.

Aberrant expression of the autoantigen heterogeneous nuclear ribonucleoprotein-A2 (RA33) and spontaneous formation of rheumatoid arthritis-associated anti-RA33 autoantibodies in TNF-alpha transgenic mice.

Hayer S, Tohidast-Akrad M, Haralambous S, Jahn-Schmid B, Skriner K, Trembleau S, Dumortier H, Pinol-Roma S, Redlich K, Schett G, Muller S, Kollias G, Smolen J, Steiner G.

J Immunol. 2005 Dec 15;175(12):8327-36.

6.

B and T cell responses to the spliceosomal heterogeneous nuclear ribonucleoproteins A2 and B1 in normal and lupus mice.

Dumortier H, Monneaux F, Jahn-Schmid B, Briand JP, Skriner K, Cohen PL, Smolen JS, Steiner G, Muller S.

J Immunol. 2000 Aug 15;165(4):2297-305.

7.

Triosephosphate isomerase- and glyceraldehyde-3-phosphate dehydrogenase-reactive autoantibodies in the cerebrospinal fluid of patients with multiple sclerosis.

Kolln J, Ren HM, Da RR, Zhang Y, Spillner E, Olek M, Hermanowicz N, Hilgenberg LG, Smith MA, van den Noort S, Qin Y.

J Immunol. 2006 Oct 15;177(8):5652-8.

8.

Cells of cerebrospinal fluid of multiple sclerosis patients secrete antibodies to myelin basic protein in vitro.

Cash E, Weerth S, Voltz R, Kornhuber M.

Scand J Immunol. 1992 Jun;35(6):695-701.

PMID:
1376491
9.

B cell epitopes of the heterogeneous nuclear ribonucleoprotein A2: identification of a new specific antibody marker for active lupus disease.

Schett G, Dumortier H, Hoefler E, Muller S, Steiner G.

Ann Rheum Dis. 2009 May;68(5):729-35. doi: 10.1136/ard.2007.087502. Epub 2008 May 21.

PMID:
18495733
10.

IgG in brain correlates with clinicopathological damage in HTLV-1 associated neurologic disease.

Jernigan M, Morcos Y, Lee SM, Dohan FC Jr, Raine C, Levin MC.

Neurology. 2003 Apr 22;60(8):1320-7.

PMID:
12707436
11.

Increased protein levels of heterogeneous nuclear ribonucleoprotein A2/B1 in fetal Down syndrome brains.

Kim SH, Dierssen M, Ferreres JC, Fountoulakis M, Lubec G.

J Neural Transm Suppl. 2001;(61):273-80.

PMID:
11771750
12.

Molecular mimicry: cross-reactive antibodies from patients with immune-mediated neurologic disease inhibit neuronal firing.

Kalume F, Lee SM, Morcos Y, Callaway JC, Levin MC.

J Neurosci Res. 2004 Jul 1;77(1):82-9.

PMID:
15197740
13.

Roles of heterogeneous nuclear ribonucleoproteins A and B in cell proliferation.

He Y, Brown MA, Rothnagel JA, Saunders NA, Smith R.

J Cell Sci. 2005 Jul 15;118(Pt 14):3173-83.

14.

Heterogeneous nuclear ribonucleoprotein h1, a novel nuclear autoantigen.

Van den Bergh K, Hooijkaas H, Blockmans D, Westhovens R, Op De Beéck K, Verschueren P, Dufour D, van de Merwe JP, Fijak M, Klug J, Michiels G, Devogelaere B, De Smedt H, Derua R, Waelkens E, Blanckaert N, Bossuyt X.

Clin Chem. 2009 May;55(5):946-54. doi: 10.1373/clinchem.2008.115626. Epub 2009 Mar 5.

15.

Prognostic and diagnostic relevance of hnRNP A2/B1, hnRNP B1 and S100 A2 in non-small cell lung cancer.

Zech VF, Dlaska M, Tzankov A, Hilbe W.

Cancer Detect Prev. 2006;30(5):395-402. Epub 2006 Oct 25.

PMID:
17067748
16.

Autoantibodies to myelin basic protein are not present in the serum and CSF of MS patients.

Brokstad KA, Page M, Nyland H, Haaheim LR.

Acta Neurol Scand. 1994 Jun;89(6):407-11.

PMID:
7526591
17.

Heterogeneous nuclear ribonucleoprotein B1 as a new marker of early detection for human lung cancers.

Sueoka E, Goto Y, Sueoka N, Kai Y, Kozu T, Fujiki H.

Cancer Res. 1999 Apr 1;59(7):1404-7.

18.

Inhibition of glyceraldehyde-3-phosphate dehydrogenase activity by antibodies present in the cerebrospinal fluid of patients with multiple sclerosis.

Kölln J, Zhang Y, Thai G, Demetriou M, Hermanowicz N, Duquette P, van den Noort S, Qin Y.

J Immunol. 2010 Aug 1;185(3):1968-75. doi: 10.4049/jimmunol.0904083. Epub 2010 Jul 7.

19.

Serum IgA reactivity against GroEL of Streptococcus sanguinis and human heterogeneous nuclear ribonucleoprotein A2/B1 in patients with Behçet disease.

Cho SB, Zheng Z, Ahn KJ, Choi MJ, Cho S, Kim DY, Lee HS, Bang D.

Br J Dermatol. 2013 May;168(5):977-83. doi: 10.1111/bjd.12128.

PMID:
23137016
20.

The rheumatoid arthritis-associated autoantigen hnRNP-A2 (RA33) is a major stimulator of autoimmunity in rats with pristane-induced arthritis.

Hoffmann MH, Tuncel J, Skriner K, Tohidast-Akrad M, Türk B, Pinol-Roma S, Serre G, Schett G, Smolen JS, Holmdahl R, Steiner G.

J Immunol. 2007 Dec 1;179(11):7568-76.

Supplemental Content

Support Center